N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction

Ji Youn Kim, Eun Young Lee, Jae Hwan Jee, Byung Wan Lee, Jae Hoon Chung, Eun Suk Jeun, Yong Ki Min, Myung Shik Lee, Kwang Won Kim, Moon Kyu Lee

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Plasma N-terminal proBNP (NT-proBNP) is released in response to pressure overload, intravascular volume expansion and myocardial ischemia from cardiac ventricles. We studied the relationship between NT-proBNP levels and left ventricular dysfunction and urinary albumin excretion in Type 2 diabetes. The study group consisted of 130 diabetic patients referred for echocardiography. They were divided into four groups according to echocardiographic finding and into three groups according to urinary albumin excretion. NT-proBNP levels were measured by electrochemiluminescence. There were significant differences in NT-proBNP levels among four groups (P = 0.012), with a highly significant difference between normal and other groups with left ventricular dysfunction. NT-proBNP levels in diastolic dysfunction were significantly higher than normal group (1491.1 pg/mL versus 232.3 pg/mL, P = 0.01), even though there was no difference in ejection fraction (EF) (61.2 ± 7.9% versus 60 ± 8.4%, P = 0.773). NT-proBNP levels showed positive correlation with age (Rs = 0.37, P < 0.001), creatinine (Rs = 0.38, P = 0.001), LVIDS (Rs = 0.56, P = 0.001) and LVIDD (Rs = 0.34, P = 0.04) and negative correlation with EF (Rs = -0.66, P = 0.001). NT-proBNP levels significantly differed among three groups according to urinary albumin excretion (P = 0.031). These results suggest that NT-proBNP could be used to identify any impairment of left ventricular function in diabetes.

Original languageEnglish
Pages (from-to)S238-S242
JournalDiabetes Research and Clinical Practice
Volume77
Issue number3 SUPPL.
DOIs
Publication statusPublished - 2007 Sep 1

Fingerprint

Brain Natriuretic Peptide
Left Ventricular Dysfunction
Type 2 Diabetes Mellitus
Albumins
Left Ventricular Function
Heart Ventricles
Myocardial Ischemia
Echocardiography
Creatinine
Pressure

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Kim, Ji Youn ; Lee, Eun Young ; Jee, Jae Hwan ; Lee, Byung Wan ; Chung, Jae Hoon ; Jeun, Eun Suk ; Min, Yong Ki ; Lee, Myung Shik ; Kim, Kwang Won ; Lee, Moon Kyu. / N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction. In: Diabetes Research and Clinical Practice. 2007 ; Vol. 77, No. 3 SUPPL. pp. S238-S242.
@article{be11fa7969494cac9dff21d787f9290b,
title = "N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction",
abstract = "Plasma N-terminal proBNP (NT-proBNP) is released in response to pressure overload, intravascular volume expansion and myocardial ischemia from cardiac ventricles. We studied the relationship between NT-proBNP levels and left ventricular dysfunction and urinary albumin excretion in Type 2 diabetes. The study group consisted of 130 diabetic patients referred for echocardiography. They were divided into four groups according to echocardiographic finding and into three groups according to urinary albumin excretion. NT-proBNP levels were measured by electrochemiluminescence. There were significant differences in NT-proBNP levels among four groups (P = 0.012), with a highly significant difference between normal and other groups with left ventricular dysfunction. NT-proBNP levels in diastolic dysfunction were significantly higher than normal group (1491.1 pg/mL versus 232.3 pg/mL, P = 0.01), even though there was no difference in ejection fraction (EF) (61.2 ± 7.9{\%} versus 60 ± 8.4{\%}, P = 0.773). NT-proBNP levels showed positive correlation with age (Rs = 0.37, P < 0.001), creatinine (Rs = 0.38, P = 0.001), LVIDS (Rs = 0.56, P = 0.001) and LVIDD (Rs = 0.34, P = 0.04) and negative correlation with EF (Rs = -0.66, P = 0.001). NT-proBNP levels significantly differed among three groups according to urinary albumin excretion (P = 0.031). These results suggest that NT-proBNP could be used to identify any impairment of left ventricular function in diabetes.",
author = "Kim, {Ji Youn} and Lee, {Eun Young} and Jee, {Jae Hwan} and Lee, {Byung Wan} and Chung, {Jae Hoon} and Jeun, {Eun Suk} and Min, {Yong Ki} and Lee, {Myung Shik} and Kim, {Kwang Won} and Lee, {Moon Kyu}",
year = "2007",
month = "9",
day = "1",
doi = "10.1016/j.diabres.2007.01.064",
language = "English",
volume = "77",
pages = "S238--S242",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "3 SUPPL.",

}

Kim, JY, Lee, EY, Jee, JH, Lee, BW, Chung, JH, Jeun, ES, Min, YK, Lee, MS, Kim, KW & Lee, MK 2007, 'N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction', Diabetes Research and Clinical Practice, vol. 77, no. 3 SUPPL., pp. S238-S242. https://doi.org/10.1016/j.diabres.2007.01.064

N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction. / Kim, Ji Youn; Lee, Eun Young; Jee, Jae Hwan; Lee, Byung Wan; Chung, Jae Hoon; Jeun, Eun Suk; Min, Yong Ki; Lee, Myung Shik; Kim, Kwang Won; Lee, Moon Kyu.

In: Diabetes Research and Clinical Practice, Vol. 77, No. 3 SUPPL., 01.09.2007, p. S238-S242.

Research output: Contribution to journalArticle

TY - JOUR

T1 - N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction

AU - Kim, Ji Youn

AU - Lee, Eun Young

AU - Jee, Jae Hwan

AU - Lee, Byung Wan

AU - Chung, Jae Hoon

AU - Jeun, Eun Suk

AU - Min, Yong Ki

AU - Lee, Myung Shik

AU - Kim, Kwang Won

AU - Lee, Moon Kyu

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Plasma N-terminal proBNP (NT-proBNP) is released in response to pressure overload, intravascular volume expansion and myocardial ischemia from cardiac ventricles. We studied the relationship between NT-proBNP levels and left ventricular dysfunction and urinary albumin excretion in Type 2 diabetes. The study group consisted of 130 diabetic patients referred for echocardiography. They were divided into four groups according to echocardiographic finding and into three groups according to urinary albumin excretion. NT-proBNP levels were measured by electrochemiluminescence. There were significant differences in NT-proBNP levels among four groups (P = 0.012), with a highly significant difference between normal and other groups with left ventricular dysfunction. NT-proBNP levels in diastolic dysfunction were significantly higher than normal group (1491.1 pg/mL versus 232.3 pg/mL, P = 0.01), even though there was no difference in ejection fraction (EF) (61.2 ± 7.9% versus 60 ± 8.4%, P = 0.773). NT-proBNP levels showed positive correlation with age (Rs = 0.37, P < 0.001), creatinine (Rs = 0.38, P = 0.001), LVIDS (Rs = 0.56, P = 0.001) and LVIDD (Rs = 0.34, P = 0.04) and negative correlation with EF (Rs = -0.66, P = 0.001). NT-proBNP levels significantly differed among three groups according to urinary albumin excretion (P = 0.031). These results suggest that NT-proBNP could be used to identify any impairment of left ventricular function in diabetes.

AB - Plasma N-terminal proBNP (NT-proBNP) is released in response to pressure overload, intravascular volume expansion and myocardial ischemia from cardiac ventricles. We studied the relationship between NT-proBNP levels and left ventricular dysfunction and urinary albumin excretion in Type 2 diabetes. The study group consisted of 130 diabetic patients referred for echocardiography. They were divided into four groups according to echocardiographic finding and into three groups according to urinary albumin excretion. NT-proBNP levels were measured by electrochemiluminescence. There were significant differences in NT-proBNP levels among four groups (P = 0.012), with a highly significant difference between normal and other groups with left ventricular dysfunction. NT-proBNP levels in diastolic dysfunction were significantly higher than normal group (1491.1 pg/mL versus 232.3 pg/mL, P = 0.01), even though there was no difference in ejection fraction (EF) (61.2 ± 7.9% versus 60 ± 8.4%, P = 0.773). NT-proBNP levels showed positive correlation with age (Rs = 0.37, P < 0.001), creatinine (Rs = 0.38, P = 0.001), LVIDS (Rs = 0.56, P = 0.001) and LVIDD (Rs = 0.34, P = 0.04) and negative correlation with EF (Rs = -0.66, P = 0.001). NT-proBNP levels significantly differed among three groups according to urinary albumin excretion (P = 0.031). These results suggest that NT-proBNP could be used to identify any impairment of left ventricular function in diabetes.

UR - http://www.scopus.com/inward/record.url?scp=34547674886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547674886&partnerID=8YFLogxK

U2 - 10.1016/j.diabres.2007.01.064

DO - 10.1016/j.diabres.2007.01.064

M3 - Article

C2 - 17490778

AN - SCOPUS:34547674886

VL - 77

SP - S238-S242

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 3 SUPPL.

ER -